MyHealthChecked PLC Notice of Results (1779L)

TIDMMHC

RNS Number : 1779L

MyHealthChecked PLC

04 September 2023

MyHealthChecked PLC

( " MyHealthChecked " or " the Company " )

Notice of results

Investor presentation

MyHealthChecked PLC (AIM: MHC), the consumer home-testing healthcare company, confirms that it will announce its interim results for the six months ended 30 June 2023 on Tuesday 19 September 2023.

Investor Briefing

Penny McCormick, Chief Executive Officer, will host a live online presentation relating to the interim results via the Investor Meet Company platform at 4.30pm on Tuesday 19 September 2023. The presentation is open to all existing and potential shareholders.

Investors can sign up to Investor Meet Company for free and register for the presentation here:

https://www.investormeetcompany.com/myhealthchecked -plc/register-investor

Investors who already follow MyHealthChecked on the Investor Meet Company platform will be automatically invited.

For further information contact:

 
 MyHealthChecked PLC                                                www.myhealthchecked.com 
 Penny McCormick, Chief Executive                                           via Walbrook PR 
  Officer 
 
 SPARK Advisory Partners Limited                                   Tel: +44 (0)20 3368 3550 
  (NOMAD) 
 Neil Baldwin / Jade Bayat 
 
 Dowgate Capital Limited (Broker)                                  Tel: +44 (0)20 3903 7715 
 David Poutney / Nicholas Chambers 
 
 Walbrook PR Ltd (Media       Tel: +44 (0)20 7933 8780 or myhealthcheckedplc@walbrookpr.com 
  & IR) 
 Paul McManus / Alice Woodings                               Mob: +44 (0)7980 541 893 / +44 
                                                                            (0)7407 804 654

About MyHealthChecked PLC ( https://investors.myhealthchecked.com/ )

MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests.

MyHealthChecked is the umbrella brand of a range of at-home rapid tests, as well as DNA, RNA and blood sample collection kits which have been created to support customers on their journeys to wellness. The tests are lateral-flow self-tests, whilst the sample collection kits enable the collection of blood, urine, nasal or mouth swab samples that are analysed in partner laboratories for a range of biomarkers. The tests will also be made available online and will be viable for over-the-counter purchase.

The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NORBUGDCRBGDGXB

(END) Dow Jones Newswires

September 04, 2023 02:00 ET (06:00 GMT)

Myhealthchecked (LSE:MHC)
Historical Stock Chart
From Nov 2024 to Dec 2024